Odyssey Therapeutics (ODTX)
Develops immune-signaling therapies for autoimmune and inflammatory diseases.
$26.90
Pre-market+0.28 (+1.07%)
At close$26.62(+8.63%)
Something off on this page? Send us feedback.
Next report
Nov 4, 2026
estimated · in 62 days
EPS estimate
−$1.08
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
—————Jun '26Aug '26Nov '26
Reported—————−$6.75−$1.26Pending
Estimate—————−$0.83−$0.83−$1.08
Surprise—————−713.3%−51.8%—
RevenueReportedEstimate
—————Jun '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$1.08 | — | — |
| Aug 2026 | −$0.83 | −$1.26 | −51.8% |
| Jun 2026 | −$0.83 | −$6.75 | −713.3% |
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 4, 2026 | −$1.08 | — | — | — | — | — | — |
| Aug 4, 2026 | −$0.83 | −$1.26 | −51.8% | — | — | — | +10.1% |
| Jun 17, 2026 | −$0.83 | −$6.75 | −713.3% | — | — | — | +3.2% |